Free Trial
ASX:DRUG

BetaShares Global Healthcare ETF - Currency Hedged (DRUG) Stock Price, News & Analysis

About BetaShares Global Healthcare ETF - Currency Hedged Stock (ASX:DRUG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$191.74 million
P/E Ratio
N/A
Dividend Yield
3.00%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DRUG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BetaShares Global Healthcare ETF - Currency Hedged and its competitors with MarketBeat's FREE daily newsletter.

DRUG Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
See More Headlines

DRUG Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that BetaShares Global Healthcare ETF - Currency Hedged investors own include Ford Motor (F), Nasstar (NASA), NVIDIA (NVDA), Netflix (NFLX), Duckhorn Portfolio (NAPA), Humana (HUM) and Google Inc. - Common Stock Ex-Distribution When Issued (GOOAV).

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Pharmaceutical Preparation Manufacturing
Sub-Industry
Pharmaceutical Products
Current Symbol
ASX:DRUG
CIK
N/A
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$191.74 million
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (ASX:DRUG) was last updated on 7/7/2025 by MarketBeat.com Staff
From Our Partners